Enhance Your Business, Join Xentria Meitheal The Connectivity Catalyst

... Xentria while at Meitheal Pharmaceuticals in a deal valued near $700 million. Jay holds a B.A. in Biology from William Jewell College and an M.B.A. from the ... Xentria's Multi-Year Licensing Agreement with Meitheal. By Martina Bellini. Perkins Coie advised Xentria Inc. on the deal. Xentria Inc., a clinical-stage ... 方代表”）及香港健友控股子公司Meitheal Pharmaceuticals, Inc.（以下简. 称“Meitheal”“被许可方”）拟与Xentria 签署《许可、开发与商业化协议》. Xentria and Meitheal Pharmaceuticals Announce Exclusive Licensing Agreement for XTMAB-16 in North AmericaAntibodies. 27 June 2023. Aldeyra Therapeutics ... Xentria and Meitheal Pharmaceuticals Announce Exclusive Licensing Agreement for XTMAB-16 in North America. 27 June 2023. Press Release: Positive topline Phase ... Xentria, Meitheal Pharma enter licensing agreement ... Chicago-based biotech Xentria announced this week that it has signed a multi-year licensing ... Xentria and Meitheal Pharmaceuticals announce exclusive licensing agreement for XTMAB-16 in North America · Spotlight · Meitheal is Ranked #4 on Crain's 2023 ... Immunology. Study Phase : Phase I/ Phase II. Recipient : Xentria. Deal Size : $680.0 million. Deal Type : Licensing Agreement. DEALS_DEV arrow-down · Xentria ... Meitheal Pharmaceuticals, Chicago, IL, Generics. Add'l Locations Novian Health ... Xentria, Chicago, IL, Biologics & Biosimilars, Monoclonal Antibody. Add'l ... Tom is the founding CEO of Meitheal since its inception in 2017. In addition, Tom is also the founding President of Xentria, Inc.